88 related articles for article (PubMed ID: 7887933)
1. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
Shum JK; Allen RA; Wong YH
Biochem Biophys Res Commun; 1995 Mar; 208(1):223-9. PubMed ID: 7887933
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
Tsu RC; Allen RA; Wong YH
Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
[TBL] [Abstract][Full Text] [Related]
3. Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
Vanek M; Hawkins LD; Gusovsky F
Mol Pharmacol; 1994 Nov; 46(5):832-9. PubMed ID: 7969069
[TBL] [Abstract][Full Text] [Related]
4. Differential coupling of the formyl peptide receptor to adenylate cyclase and phospholipase C by the pertussis toxin-insensitive Gz protein.
Tsu RC; Lai HW; Allen RA; Wong YH
Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):331-9. PubMed ID: 7619076
[TBL] [Abstract][Full Text] [Related]
5. C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.
Monk PN; Pease JE; Barker MD
Biochem Mol Biol Int; 1994 Jan; 32(1):13-20. PubMed ID: 8012277
[TBL] [Abstract][Full Text] [Related]
6. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.
Wang C; Gerard NP; Nicholson-Weller A
J Immunol; 1996 Jan; 156(2):786-92. PubMed ID: 8543834
[TBL] [Abstract][Full Text] [Related]
7. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
8. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
9. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
10. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
Law SF; Zaina S; Sweet R; Yasuda K; Bell GI; Stadel J; Reisine T
Mol Pharmacol; 1994 Apr; 45(4):587-90. PubMed ID: 8183236
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
12. Multiple effector coupling of somatostatin receptor subtype SSTR1.
Kubota A; Yamada Y; Kagimoto S; Yasuda K; Someya Y; Ihara Y; Okamoto Y; Kozasa T; Seino S; Seino Y
Biochem Biophys Res Commun; 1994 Oct; 204(1):176-86. PubMed ID: 7524497
[TBL] [Abstract][Full Text] [Related]
13. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha.
Conklin BR; Farfel Z; Lustig KD; Julius D; Bourne HR
Nature; 1993 May; 363(6426):274-6. PubMed ID: 8387644
[TBL] [Abstract][Full Text] [Related]
14. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation.
Garnovskaya MN; Nebigil CG; Arthur JM; Spurney RF; Raymond JR
Mol Pharmacol; 1995 Aug; 48(2):230-7. PubMed ID: 7651356
[TBL] [Abstract][Full Text] [Related]
16. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
17. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
18. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
19. Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor.
Lee CH; Katz A; Simon MI
Mol Pharmacol; 1995 Feb; 47(2):218-23. PubMed ID: 7870028
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.
Xie P; Nishiura H; Semba U; Chen J; Zhao R; Kuniyasu A; Yamamoto T
Int Immunopharmacol; 2012 Jan; 12(1):158-68. PubMed ID: 22155625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
